Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice

Author:

Ida Hanae1ORCID,Koyama Takafumi1ORCID,Mizuno Takaaki1,Sunami Kuniko2ORCID,Kubo Takashi2,Sudo Kazuki13ORCID,Tao Kayoko4,Hirata Makoto5,Yonemori Kan13ORCID,Kato Ken67ORCID,Okusaka Takuji8,Ohe Yuichiro9ORCID,Matsui Yoshiyuki10,Yamazaki Naoya11ORCID,Ogawa Chitose4,Kawai Akira12ORCID,Narita Yoshitaka13,Esaki Minoru14,Yamamoto Noboru19ORCID

Affiliation:

1. Department of Experimental Therapeutics National Cancer Center Hospital Tokyo Japan

2. Department of Laboratory Medicine National Cancer Center Hospital Tokyo Japan

3. Department of Medical Oncology National Cancer Center Hospital Tokyo Japan

4. Department of Pediatric Oncology National Cancer Center Hospital Tokyo Japan

5. Department of Genetic Medicine and Services National Cancer Center Hospital Tokyo Japan

6. Department of Gastrointestinal Medical Oncology National Cancer Center Hospital Tokyo Japan

7. Department of Head and Neck, Esophageal Medical Oncology National Cancer Center Hospital Tokyo Japan

8. Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital Tokyo Japan

9. Department of Thoracic Oncology National Cancer Center Hospital Tokyo Japan

10. Department of Urology National Cancer Center Hospital Tokyo Japan

11. Department of Dermatologic Oncology National Cancer Center Hospital Tokyo Japan

12. Department of Musculoskeletal Oncology and Rehabilitation National Cancer Center Hospital Tokyo Japan

13. Department of Neurosurgery and Neuro‐Oncology National Cancer Center Hospital Tokyo Japan

14. Department of Hepatobiliary and Pancreatic Surgery National Cancer Center Hospital Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference18 articles.

1. Precision oncology and the universal health coverage system in Japan;Ebi H;JCO Precis Oncol,2019

2. https://products.sysmex.co.jp/products/genetic/AK401170/index.html

3. https://www.foundationmedicine.com/test/foundationone‐cdx

4. Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study

5. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3